News
Filter
-
Research shows potential ‘life-transforming’ mole reversal therapy in rare condition
-
LifeArc announces research funding boost to address dengue fever amid growing global health threat
-
LifeArc co-funds a new blood test that could prevent sudden child deaths caused by hereditary heart condition
-
The new LifeArc identity: More than just a fresh coat of paint
-
New partnership aims to develop clinical tools for motor neuron disease prognosis, monitoring, and drug development
-
Hope for children with cancer: LifeArc and CureSearch fund research into whether a modified cold sore virus, combined with a vaccine, could cure brain cancer
-
LifeArc backs new report that warns UK business R&D investment has ‘stagnated’ and calls for improved investment incentives
-
LifeArc and Kings College London team up to accelerate MND treatment development by driving systematic target validation
-
Britain’s largest health research programme, Our Future Health, forms new £10m partnership with LifeArc
-
LifeArc welcomes the UK government’s national action plan for antimicrobial resistance (AMR)
-
LifeArc Translational Science Summit: Highlights and key takeaways
-
LifeArc launches £40m research centres that will unlock new tests, treatments and cures for people living with rare diseases
